ALPN logo

Alpine Immune Sciences (ALPN) Net Income

Annual Net Income

-$32.18 M
+$25.58 M+44.28%

December 31, 2023

Summary

Performance

1-Year Change

+44.28%

3-Year Change

-15.19%

5-Year Change

+11.79%

15-Year Change

-313.52%

ALPN Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$7.78 M

3-Year Low

-$57.76 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ALPN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ALPN next annual earnings announcement has not yet been scheduled

OtherALPNprofitabilitymetrics:

Annual Net Margin

-54.66%
ALPN annual net profit margin is -54.66%

Annual Revenue

$58.88 M
ALPN annual revenue is $58.88 million

Annual Gross Profit

-
ALPN annual gross profit value is unknown

Annual EPS

-$0.64
ALPN annual earnings per share is -$0.64

Quarterly Net Income

-$17.92 M
-$23.88 M-400.64%

March 1, 2024

Summary

Performance

3-Month Change

-400.64%

1-Year Change

-52.86%

3-Year Change

-52.86%

5-Year Change

-52.86%

ALPN Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.96 M
ALPN quarterly net profit is currently -400.64% below its historical high of $5.96 million

3-Year Low

-$18.86 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 1, 2024
ALPN previous earnings announcement was published on Mar 1, 2024

Next Quarterly Earnings Report Date

N/A
ALPN next earnings announcement has not yet been scheduled

OtherALPNprofitabilitymetrics:

Quarterly Net Margin

-254.81%
ALPN quarterly net profit margin is -254.81%

Quarterly Revenue

$7.03 M
ALPN quarterly revenue is $7.03 million

Quarterly Gross Profit

-
ALPN quarterly gross profit value is unknown

Quarterly EPS

-$0.28
ALPN quarterly earnings per share is -$0.28

TTM Net Income

-$36.84 M
-$4.65 M-14.45%

March 1, 2024

Summary

Performance

3-Month Change

-14.45%

1-Year Change

+35.38%

3-Year Change

+35.38%

5-Year Change

+35.38%

ALPN TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.35 M

3-Year Low

-$63.50 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 1, 2024
ALPN previous earnings announcement was published on Mar 1, 2024

Next Quarterly Earnings Report Date

N/A
ALPN next earnings announcement has not yet been scheduled

OtherALPNprofitabilitymetrics:

Annual Net Margin

-54.66%
ALPN annual net profit margin is -54.66%

TTM Revenue

$56.52 M
ALPN TTM revenue is $56.52 million

TTM Gross Profit

-
ALPN TTM gross profit value is unknown

TTM EPS

-$0.64
ALPN TTM earnings per share is -$0.64

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$32.18 M
ALPN annual net profit is -$32.18 million

Annual Revenue

$58.88 M
ALPN annual revenue is $58.88 million

Annual Cost Of Goods Sold

-
ALPN annual cost of goods sold value is unknown

Annual Operating Expenses

$103.13 M
ALPN annual total operating expenses is $103.13 million

Annual Interest Expense

$98.00 K
ALPN annual interest expense is $98.00 thousand

Annual Income Tax

$103.00 K
ALPN annual income tax is $103.00 thousand

ALPN Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.3%-52.9%+35.4%
3 y3 years-15.2%-52.9%+35.4%
5 y5 years+11.8%-52.9%+35.4%

ALPN Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+79.5%-400.6%+5.3%+14.5%+72.4%
5 y5-year+15.2%+79.5%-400.6%+5.3%+32.8%+72.4%
alltimeall time+313.5%+79.5%-400.6%+5.3%+746.8%+72.4%

Alpine Immune Sciences Net Income History

DateAnnualQuarterlyTTM
Mar 2024
-
-$17.92 M(-400.6%)
-$36.84 M(+14.5%)
Dec 2023
-$32.18 M(-44.3%)
$5.96 M(-150.8%)
-$32.18 M(-43.5%)
Sep 2023
-
-$11.72 M(-10.9%)
-$57.01 M(-2.6%)
Jun 2023
-
-$13.16 M(-0.8%)
-$58.56 M(-7.8%)
Mar 2023
-
-$13.27 M(-29.7%)
-$63.50 M(+9.9%)
Dec 2022
-$57.76 M(+14.8%)
-$18.86 M(+42.1%)
-$57.76 M(+6.8%)
Sep 2022
-
-$13.27 M(-26.7%)
-$54.06 M(-0.4%)
Jun 2022
-
-$18.10 M(+140.4%)
-$54.29 M(+15.0%)
Mar 2022
-
-$7.53 M(-50.4%)
-$47.22 M(-6.2%)
Dec 2021
-$50.33 M(+80.1%)
-$15.17 M(+12.4%)
-$50.33 M(+21.3%)
Sep 2021
-
-$13.49 M(+22.4%)
-$41.51 M(+21.5%)
Jun 2021
-
-$11.03 M(+3.6%)
-$34.15 M(+3.3%)
Mar 2021
-
-$10.64 M(+67.8%)
-$33.05 M(+18.3%)
Dec 2020
-$27.94 M(-33.2%)
-$6.34 M(+3.3%)
-$27.94 M(+0.7%)
Sep 2020
-
-$6.14 M(-38.2%)
-$27.74 M(-16.1%)
Jun 2020
-
-$9.93 M(+79.4%)
-$33.08 M(-5.5%)
Mar 2020
-
-$5.53 M(-9.9%)
-$35.00 M(-16.4%)
Dec 2019
-$41.85 M(+14.7%)
-$6.14 M(-46.5%)
-$41.85 M(-10.7%)
Sep 2019
-
-$11.47 M(-3.2%)
-$46.85 M(-1.4%)
Jun 2019
-
-$11.86 M(-4.2%)
-$47.51 M(+9.1%)
Mar 2019
-
-$12.38 M(+11.2%)
-$43.56 M(+19.4%)
DateAnnualQuarterlyTTM
Dec 2018
-$36.49 M(+368.8%)
-$11.13 M(-8.3%)
-$36.49 M(+23.0%)
Sep 2018
-
-$12.14 M(+53.5%)
-$29.67 M(+92.5%)
Jun 2018
-
-$7.91 M(+49.0%)
-$15.41 M(+37.4%)
Mar 2018
-
-$5.31 M(+22.9%)
-$11.21 M(-24.4%)
Dec 2017
-$7.78 M(-75.3%)
-$4.32 M(-303.5%)
-$14.82 M(-18.6%)
Sep 2017
-
$2.12 M(-157.2%)
-$18.22 M(-34.4%)
Jun 2017
-
-$3.71 M(-58.4%)
-$27.77 M(-14.7%)
Mar 2017
-
-$8.92 M(+15.6%)
-$32.54 M(+3.4%)
Dec 2016
-$31.46 M(+37.9%)
-$7.71 M(+3.8%)
-$31.46 M(+3.8%)
Sep 2016
-
-$7.43 M(-12.3%)
-$30.31 M(+4.6%)
Jun 2016
-
-$8.48 M(+8.2%)
-$28.97 M(+10.0%)
Mar 2016
-
-$7.84 M(+19.4%)
-$26.34 M(+15.4%)
Dec 2015
-$22.82 M(+51.8%)
-$6.56 M(+7.8%)
-$22.82 M(+15.6%)
Sep 2015
-
-$6.09 M(+4.0%)
-$19.74 M(+18.5%)
Jun 2015
-
-$5.85 M(+35.7%)
-$16.66 M(+11.1%)
Mar 2015
-
-$4.31 M(+23.8%)
-$15.00 M(-0.2%)
Dec 2014
-$15.04 M(-7.2%)
-$3.49 M(+15.8%)
-$15.04 M(+30.2%)
Sep 2014
-
-$3.01 M(-28.1%)
-$11.55 M(+35.3%)
Jun 2014
-
-$4.19 M(-3.7%)
-$8.54 M(+96.3%)
Mar 2014
-
-$4.35 M
-$4.35 M
Dec 2013
-$16.20 M(+69.2%)
-
-
Dec 2012
-$9.57 M
-
-

FAQ

  • What is Alpine Immune Sciences annual net profit?
  • What is the all time high annual net income for Alpine Immune Sciences?
  • What is Alpine Immune Sciences annual net income year-on-year change?
  • What is Alpine Immune Sciences quarterly net profit?
  • What is the all time high quarterly net income for Alpine Immune Sciences?
  • What is Alpine Immune Sciences quarterly net income year-on-year change?
  • What is Alpine Immune Sciences TTM net profit?
  • What is the all time high TTM net income for Alpine Immune Sciences?
  • What is Alpine Immune Sciences TTM net income year-on-year change?

What is Alpine Immune Sciences annual net profit?

The current annual net income of ALPN is -$32.18 M

What is the all time high annual net income for Alpine Immune Sciences?

Alpine Immune Sciences all-time high annual net profit is -$7.78 M

What is Alpine Immune Sciences annual net income year-on-year change?

Over the past year, ALPN annual net profit has changed by +$25.58 M (+44.28%)

What is Alpine Immune Sciences quarterly net profit?

The current quarterly net income of ALPN is -$17.92 M

What is the all time high quarterly net income for Alpine Immune Sciences?

Alpine Immune Sciences all-time high quarterly net profit is $5.96 M

What is Alpine Immune Sciences quarterly net income year-on-year change?

Over the past year, ALPN quarterly net profit has changed by -$6.20 M (-52.86%)

What is Alpine Immune Sciences TTM net profit?

The current TTM net income of ALPN is -$36.84 M

What is the all time high TTM net income for Alpine Immune Sciences?

Alpine Immune Sciences all-time high TTM net profit is -$4.35 M

What is Alpine Immune Sciences TTM net income year-on-year change?

Over the past year, ALPN TTM net profit has changed by +$20.17 M (+35.38%)